ESPR Operating Cash Flow (Statement)
Esperion Therapeutics Inc · Operating Cash Flow (Statement)
ESPR Operating Cash Flow (Statement)
Latest reported-$27.72Mperiod ending
ESPR Quarterly Cash from Operations (-$4.39M → -$27.72M)
Quarterly operating cash flow (statement)
High-resolution chart · PNG
ESPR operating cash flow (statement) history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -27,722,000 | |
| 45,243,000 | |
| -4,286,000 | |
| -31,422,000 | |
| -22,628,000 | |
| -34,952,000 | |
| -35,325,000 | |
| -7,205,000 | |
| 53,828,000 | |
| -37,056,000 | |
| -19,325,000 | |
| -24,750,000 | |
| -54,356,000 | |
| -42,253,000 | |
| -43,052,000 | |
| -50,532,000 | |
| -38,990,000 | |
| -57,706,000 | |
| -69,169,000 | |
| -47,866,000 | |
| -89,068,000 | |
| -68,550,000 | |
| -86,671,000 | |
| 139,391,000 | |
| -69,347,000 | |
| -49,994,000 | |
| -58,029,000 | |
| -54,009,000 | |
| 91,691,000 | |
| -28,692,000 | |
| -37,527,000 | |
| -39,198,000 | |
| -43,221,000 | |
| -34,874,000 | |
| -35,884,000 | |
| -26,228,000 | |
| -34,316,000 | |
| -16,316,000 | |
| -14,304,000 | |
| -7,307,000 | |
| -9,803,000 | |
| -8,449,000 | |
| -11,830,000 | |
| -8,614,000 | |
| -9,263,000 | |
| -8,208,000 | |
| -8,631,000 | |
| -6,078,000 | |
| -9,104,000 | |
| -7,530,349 | |
| -4,776,896 | |
| -3,179,546 | |
| -2,626,570 | |
| -2,369,804 | |
| -2,906,164 | |
| -2,847,094 | |
| -2,685,505 | |
| -7,163,000 | |
| -6,089,000 | |
| -6,974,000 | |
| -5,615,000 | |
| -6,685,000 | |
| -7,006,000 | |
| -7,258,000 | |
| -6,034,000 | |
| -5,246,000 | |
| -5,847,000 | |
| -5,640,000 | |
| -5,742,000 | |
| -3,324,000 | |
| -4,499,396 | |
| -4,388,604 |